{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T23:25:31Z","timestamp":1768346731326,"version":"3.49.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T00:00:00Z","timestamp":1574726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T00:00:00Z","timestamp":1574726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s11910-019-1015-y","type":"journal-article","created":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T14:02:42Z","timestamp":1574776962000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Atypical Pediatric Demyelinating Diseases of the Central Nervous System"],"prefix":"10.1007","volume":"19","author":[{"given":"Regina M.","family":"Troxell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Christy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,26]]},"reference":[{"key":"1015_CR1","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1212\/WNL.0b013e31822facdd","volume":"77","author":"A Langer-Gould","year":"2011","unstructured":"Langer-Gould A, Zhang JL, Chung J, Yeung Y, Waubant E, Yao J. Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children. Neurology. 2011;77:1143\u20138.","journal-title":"Neurology"},{"issue":"1","key":"1015_CR2","doi-asserted-by":"publisher","first-page":"e20160120","DOI":"10.1542\/peds.2016-0120","volume":"138","author":"A. L. Belman","year":"2016","unstructured":"Belman AL, Krupp LB, Olsen CS, Rose JW, Aaen G, Benson L, et al. Network of Pediatric MS Centers. Characteristics of Children and Adolescents With Multiple Sclerosis. 2016 Pediatrics Jul;138(1). pii: e20160120. https:\/\/doi.org\/10.1542\/peds.2016-0120.","journal-title":"PEDIATRICS"},{"issue":"Pt 11","key":"1015_CR3","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1093\/brain\/120.11.2059","volume":"120","author":"F Barkhof","year":"1997","unstructured":"Barkhof F, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain. 1997;120(Pt 11):2059\u201369.","journal-title":"Brain"},{"key":"1015_CR4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17:162\u201373.","journal-title":"Lancet Neurol."},{"key":"1015_CR5","doi-asserted-by":"publisher","first-page":"e528","DOI":"10.1212\/NXI.0000000000000528","volume":"6","author":"YYM Wong","year":"2019","unstructured":"\u2022\u2022 Wong YYM, et al. Real-world validation of the 2017 McDonald criteria for pediatric MS. Neurol Neuroimmunol. Neuroinflamm. 2019;6:e528 This study evaluates the specificity and sensitivity of the 2017 McDonald criteria for MS in children, particularly those under 12.","journal-title":"Neurol Neuroimmunol. Neuroinflamm"},{"key":"1015_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85:177\u201389.","journal-title":"Neurology"},{"key":"1015_CR7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1212\/WNL.0000000000002283","volume":"86","author":"T Chitnis","year":"2016","unstructured":"Chitnis T, Ness J, Krupp L, Waubant E, Hunt T, Olsen CS, et al. Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report. Neurology. 2016;86:245\u201352.","journal-title":"Neurology"},{"key":"1015_CR8","doi-asserted-by":"publisher","first-page":"S7 LP","DOI":"10.1212\/01.wnl.0000259422.44235.a8","volume":"68","author":"LB Krupp","year":"2007","unstructured":"Krupp LB, Banwell B, Tenembaum S. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology. 2007;68:S7 LP\u2013S12.","journal-title":"Neurology"},{"key":"1015_CR9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11940-019-0541-x","volume":"21","author":"Y Hacohen","year":"2019","unstructured":"\u2022\u2022 Hacohen Y, Banwell B. Treatment approaches for MOG-Ab-associated demyelination in children. Curr Treat Options Neurol. 2019;21:2 This review summarizes key publications reporting clinical presentation, antibody-detection, neuroimaging, and treatment of MOG-antibody associated demyelinating disease in children.","journal-title":"Curr Treat Options Neurol"},{"key":"1015_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41582-018-0112-x","volume":"15","author":"M Reindl","year":"2019","unstructured":"Reindl M, Waters P. Myelin oligodendrocyte glycoprotein antibodies in neurological disease. Nat Rev Neurol. 2019;15:89\u2013102.","journal-title":"Nat Rev Neurol"},{"key":"1015_CR11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1055\/s-0036-1583184","volume":"47","author":"S Thulasirajah","year":"2016","unstructured":"Thulasirajah S, Pohl D, Davila-Acosta J, Venkateswaran S. Myelin oligodendrocyte glycoprotein-associated pediatric central nervous system demyelination: clinical course, Neuroimaging Findings, and Response to Therapy. Neuropediatrics. 2016;47:245\u201352.","journal-title":"Neuropediatrics"},{"key":"1015_CR12","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1177\/1352458515587751","volume":"22","author":"C Fernandez-Carbonell","year":"2016","unstructured":"Fernandez-Carbonell C, Vargas-Lowy D, Musallam A, Healy B, McLaughlin K, Wucherpfennig KW, et al. Clinical and MRI phenotype of children with MOG antibodies. Mult Scler. 2016;22:174\u201384.","journal-title":"Mult Scler"},{"key":"1015_CR13","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1177\/0961203318772021","volume":"27","author":"GY Ahn","year":"2018","unstructured":"Ahn GY, Kim D, Won S, Song ST, Jeong HJ, Sohn IW, et al. Prevalence, risk factors, and impact on mortality of neuropsychiatric lupus: a prospective, single-center study. Lupus. 2018;27:1338\u201347.","journal-title":"Lupus"},{"key":"1015_CR14","doi-asserted-by":"publisher","unstructured":"Li X, Xiang X, Sun J, Liu S, Liu Y, Feng L, et al. Prevalence, outcome and prognostic factors of neuropsychiatric systemic lupus erythematosus: a real world single center study. Mod Rheumatol. 2019:1\u20136. https:\/\/doi.org\/10.1080\/14397595.2019.1589912.","DOI":"10.1080\/14397595.2019.1589912"},{"key":"1015_CR15","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/j.1755-3768.2008.01193.x","volume":"87","author":"Y-C Lin","year":"2009","unstructured":"Lin Y-C, Wang A-G, Yen M-Y. Systemic lupus erythematosus-associated optic neuritis: clinical experience and literature review. Acta Ophthalmol. 2009;87:204\u201310.","journal-title":"Acta Ophthalmol."},{"key":"1015_CR16","doi-asserted-by":"publisher","first-page":"16005","DOI":"10.1038\/scsandc.2016.5","volume":"2","author":"JP Hryb","year":"2016","unstructured":"Hryb JP, et al. Myelitis in systemic lupus erythematosus: clinical features, immunological profile and magnetic resonance imaging of five cases. Spinal Cord Ser Cases. 2016;2:16005.","journal-title":"Spinal Cord Ser Cases"},{"key":"1015_CR17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1177\/0961203314547795","volume":"24","author":"J Saison","year":"2015","unstructured":"Saison J, Costedoat-Chalumeau N, Maucort-Boulch D, Iwaz J, Marignier R, Cacoub P, et al. Systemic lupus erythematosus-associated acute transverse myelitis: manifestations, treatments, outcomes, and prognostic factors in 20 patients. Lupus. 2015;24:74\u201381.","journal-title":"Lupus"},{"key":"1015_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.berh.2013.07.010","volume":"27","author":"C Magro Checa","year":"2013","unstructured":"Magro Checa C, Cohen D, Bollen EL, van Buchem M, Huizinga TW, Steup-Beekman GM. Demyelinating disease in SLE: is it multiple sclerosis or lupus? Best Pract Res Clin Rheumatol. 2013;27:405\u201324.","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"1015_CR19","first-page":"504","volume":"39","author":"P Dore-Duffy","year":"1982","unstructured":"Dore-Duffy P, Donaldson JO, Rothman BL, Zurier RB. Antinuclear antibodies in multiple sclerosis. JAMA Neurol. 1982;39:504\u20136.","journal-title":"JAMA Neurol."},{"key":"1015_CR20","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1177\/0961203311427550","volume":"21","author":"M Szmyrka-Kaczmarek","year":"2012","unstructured":"Szmyrka-Kaczmarek M, Pokryszko-Dragan A, Pawlik B, Gruszka E, Korman L, Podemski R, et al. Antinuclear and antiphospholipid antibodies in patients with multiple sclerosis. Lupus. 2012;21:412\u201320.","journal-title":"Lupus"},{"key":"1015_CR21","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.semarthrit.2016.09.010","volume":"46","author":"M Merashli","year":"2017","unstructured":"Merashli M, Alves JD, Gentile F, Ames PRJ. Relevance of antiphospholipid antibodies in multiple sclerosis: a systematic review and meta analysis. Semin Arthritis Rheum. 2017;46:810\u20138.","journal-title":"Semin Arthritis Rheum."},{"key":"1015_CR22","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1093\/rheumatology\/key282","volume":"58","author":"A-K Probstel","year":"2019","unstructured":"Probstel A-K, et al. Association of antibodies against myelin and neuronal antigens with neuroinflammation in systemic lupus erythematosus. Rheumatology (Oxford). 2019;58:908\u201313.","journal-title":"Rheumatology (Oxford)."},{"key":"1015_CR23","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/BOR.0b013e32833cc9b7","volume":"22","author":"S Ozen","year":"2010","unstructured":"Ozen S. Pediatric onset Behcet disease. Curr Opin Rheumatol. 2010;22:585\u20139.","journal-title":"Curr Opin Rheumatol"},{"key":"1015_CR24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12969-016-0070-z","volume":"14","author":"I Kon\u00e9-Paut","year":"2016","unstructured":"Kon\u00e9-Paut I. Beh\u00e7et\u2019s disease in children, an overview. Pediatr Rheumatol. 2016;14:10.","journal-title":"Pediatr Rheumatol"},{"key":"1015_CR25","first-page":"S80","volume":"33","author":"G Akman-Demir","year":"2015","unstructured":"Akman-Demir G, Mutlu M, Kiyat-Atamer A, Shugaiv E, Kurtuncu M, Tugal-Tutkun I, et al. Behcet\u2019s disease patients with multiple sclerosis-like features: discriminative value of Barkhof criteria. Clin Exp Rheumatol. 2015;33:S80\u20134.","journal-title":"Clin Exp Rheumatol"},{"key":"1015_CR26","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s10067-010-1650-9","volume":"30","author":"A Borhani Haghighi","year":"2011","unstructured":"Borhani Haghighi A, Sarhadi S, Farahangiz S. MRI findings of neuro-Behcet\u2019s disease. Clin Rheumatol. 2011;30:765\u201370.","journal-title":"Clin Rheumatol"},{"key":"1015_CR27","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1111\/1756-185X.12013","volume":"15","author":"S Farahangiz","year":"2012","unstructured":"Farahangiz S, Sarhadi S, Safari A, Borhani-Haghighi A. Magnetic resonance imaging findings and outcome of neuro-Behcet\u2019s disease: the predictive factors. Int J Rheum Dis. 2012;15:e142\u20139.","journal-title":"Int J Rheum Dis"},{"key":"1015_CR28","doi-asserted-by":"publisher","first-page":"577002","DOI":"10.1016\/j.jneuroim.2019.577002","volume":"334","author":"J Fujimori","year":"2019","unstructured":"Fujimori J, et al. Two Japanese cases of anti-MOG antibody-associated encephalitis that mimicked neuro-Behcet\u2019s disease. J Neuroimmunol. 2019;334:577002.","journal-title":"J Neuroimmunol"},{"key":"1015_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.5114\/reum.2018.75521","volume":"56","author":"J Perzynska-Mazan","year":"2018","unstructured":"Perzynska-Mazan J, Maslinska M, Gasik R. Neurological manifestations of primary Sjogren\u2019s syndrome. Reumatologia. 2018;56:99\u2013105.","journal-title":"Reumatologia"},{"key":"1015_CR30","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1002\/acr.23107","volume":"69","author":"J Birnbaum","year":"2017","unstructured":"Birnbaum J, Atri NM, Baer AN, Cimbro R, Montagne J, Casciola-Rosen L. Relationship between neuromyelitis optica spectrum disorder and Sjogren\u2019s syndrome: central nervous system extraglandular disease or unrelated, co-occurring autoimmunity? Arthritis Care Res (Hoboken). 2017;69:1069\u201375.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1015_CR31","first-page":"102","volume":"6","author":"K Jobling","year":"2018","unstructured":"Jobling K, Ledingham D, Ng W-F, Guadagno J. Positive anti-MOG antibodies in a patient with Sjogren\u2019s syndrome and transverse myelitis. Eur J Rheumatol. 2018;6:102\u20134.","journal-title":"Eur J Rheumatol"},{"key":"1015_CR32","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1086\/656812","volume":"51","author":"A Uriel","year":"2010","unstructured":"Uriel A, et al. Tumefactive demyelination-an unusual neurological presentation of HIV. Clin Infect Dis. 2010;51:1217\u201320.","journal-title":"Clin Infect Dis"},{"key":"1015_CR33","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.ejpn.2005.02.002","volume":"9","author":"R van Toorn","year":"2005","unstructured":"van Toorn R, Kritzinger F, Rabie H. Acute demyelinating encephalomyelitis (ADEM), cryptococcal reactivation and disseminated herpes simplex in an HIV infected child following HAART. Eur J Paediatr Neurol. 2005;9:355\u20139.","journal-title":"Eur J Paediatr Neurol"},{"key":"1015_CR34","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/0883073810375717","volume":"26","author":"MS Tullu","year":"2011","unstructured":"Tullu MS, Patil DP, Muranjan MN, Kher AS, Lahiri KR. Human immunodeficiency virus (HIV) infection in a child presenting as acute disseminated encephalomyelitis. J Child Neurol. 2011;26:99\u2013102.","journal-title":"J Child Neurol"},{"key":"1015_CR35","doi-asserted-by":"publisher","first-page":"150","DOI":"10.4103\/1817-1745.139326","volume":"9","author":"KC Patra","year":"2014","unstructured":"Patra KC, Shirolkar MS, Ghane VR. Acute disseminated encephalomyelitis: extremely rare presentation of pediatric human immunodeficiency virus infection. J Pediatr Neurosci. 2014;9:150\u20133.","journal-title":"J Pediatr Neurosci"},{"key":"1015_CR36","doi-asserted-by":"publisher","first-page":"471 LP","DOI":"10.1128\/CMR.05031-11","volume":"25","author":"MW Ferenczy","year":"2012","unstructured":"Ferenczy MW, et al. Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev. 2012;25:471 LP\u2013506.","journal-title":"Clin Microbiol Rev"},{"key":"1015_CR37","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1055\/s-0036-1583609","volume":"47","author":"EM Hennes","year":"2016","unstructured":"Hennes EM, Kornek B, Huppke P, Reindl M, Rostasy K, Berger T. Age-dependent seroprevalence of JCV antibody in children. Neuropediatrics. 2016;47:112\u20134.","journal-title":"Neuropediatrics"},{"key":"1015_CR38","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1177\/1352458514543340","volume":"21","author":"P Huppke","year":"2015","unstructured":"Huppke P, Hummel H, Ellenberger D, Pfeifenbring S, Stark W, Huppke B, et al. JC virus antibody status in a pediatric multiple sclerosis cohort: prevalence, conversion rate and influence on disease severity. Mult Scler. 2015;21:382\u20137.","journal-title":"Mult Scler"},{"key":"1015_CR39","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1212\/WNL.0b013e31828c2fa1","volume":"80","author":"JR Berger","year":"2013","unstructured":"Berger JR, Aksamit AJ, Clifford DB, Davis L, Koralnik IJ, Sejvar JJ, et al. PML diagnostic criteria: consensus statement from the AAN neuroinfectious disease section. Neurology. 2013;80:1430\u20138.","journal-title":"Neurology"},{"key":"1015_CR40","unstructured":"Centers for Disease Control and Prevention. Measles cases and outbreaks. 2019. Available at: https:\/\/www.cdc.gov\/measles\/cases-outbreaks.html. Accessed 17th June 2019."},{"issue":"10","key":"1015_CR41","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1111\/dmcn.14166","volume":"61","author":"Mohammed Mekki","year":"2019","unstructured":"Mekki M, Eley B, Hardie D, Wilmshurst JM. Subacute sclerosing panencephalitis: clinical phenotype, epidemiology, and preventive interventions. Dev Med Child Neurol. 2019. https:\/\/doi.org\/10.1111\/dmcn.14166.","journal-title":"Developmental Medicine & Child Neurology"},{"key":"1015_CR42","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/pmj.78.916.63","volume":"78","author":"RK Garg","year":"2002","unstructured":"Garg RK. Subacute sclerosing panencephalitis. Postgrad Med J. 2002;78:63\u201370.","journal-title":"Postgrad Med J"},{"key":"1015_CR43","first-page":"67","volume":"9","author":"SK Jafri","year":"2018","unstructured":"Jafri SK, Kumar R, Ibrahim SH. Subacute sclerosing panencephalitis - current perspectives. Pediatr Heal Med Ther. 2018;9:67\u201371.","journal-title":"Pediatr Heal Med Ther"},{"key":"1015_CR44","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1055\/s-0038-1675628","volume":"50","author":"SR Dhawan","year":"2019","unstructured":"Dhawan SR, Kesavan S, Saini L, Singh P, Sahu JK, Sankhyan N. Diffuse white matter involvement in subacute sclerosing panencephalitis. Neuropediatrics. 2019;50:68\u201370.","journal-title":"Neuropediatrics"},{"key":"1015_CR45","doi-asserted-by":"publisher","first-page":"275","DOI":"10.4103\/0972-2327.173304","volume":"19","author":"B Das","year":"2016","unstructured":"Das B, Goyal MK, Modi M, Mehta S, Chakravarthi S, Lal V, et al. Atypical magnetic resonance imaging features in subacute sclerosing panencephalitis. Ann Indian Acad Neurol. 2016;19:275\u20136.","journal-title":"Ann Indian Acad Neurol"},{"key":"1015_CR46","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/1941874418776902","volume":"9","author":"HV Tandra","year":"2019","unstructured":"Tandra HV, Roy PS, Sharma R, Bhatia V, Saini AG. Subacute sclerosing panencephalitis presenting as choreoathetosis and basal ganglia hyperintensities. Neurohospitalist. 2019;9:26\u20139.","journal-title":"Neurohospitalist"},{"issue":"dec14 1","key":"1015_CR47","doi-asserted-by":"publisher","first-page":"bcr2012006764","DOI":"10.1136\/bcr-2012-006764","volume":"2012","author":"T. P. Raut","year":"2012","unstructured":"Raut TP, Singh MK, Garg RK, Naphade PU. Subacute sclerosing panencephalitis presenting as neuromyelitis optica. BMJ Case Rep. 2012 Dec 14;2012. pii: bcr2012006764. https:\/\/doi.org\/10.1136\/bcr-2012-006764.","journal-title":"Case Reports"},{"key":"1015_CR48","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/tropej\/fmm020","volume":"53","author":"C Yilmaz","year":"2007","unstructured":"Yilmaz C, Caksen H, Yilmaz N, Guven AS, Bayram I. Two cases of subacute sclerosing panencephalitis associated with brainstem involvement. J Trop Pediatr. 2007;53:280\u20133.","journal-title":"J Trop Pediatr"},{"key":"1015_CR49","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1001\/archneur.1975.00490530041002","volume":"32","author":"ON Markand","year":"1975","unstructured":"Markand ON, Panszi JG. The electroencephalogram in subacute sclerosing panencephalitis. Arch Neurol. 1975;32:719\u201326.","journal-title":"Arch Neurol"},{"key":"1015_CR50","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1177\/155005949502600404","volume":"26","author":"CF Dogulu","year":"1995","unstructured":"Dogulu CF, Ciger A, Saygi S, Renda Y, Yalaz K. Atypical EEG findings in subacute sclerosing panencephalitis. Clin Electroencephalogr. 1995;26:193\u20139.","journal-title":"Clin Electroencephalogr"},{"key":"1015_CR51","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3345\/kjp.2018.06730","volume":"62","author":"M Kwak","year":"2019","unstructured":"Kwak M, Yeh HR, Yum MS, Kim HJ, You SJ, Ko TS. A long-term subacute sclerosing panencephalitis survivor treated with intraventricular interferon-alpha for 13 years. Korean J Pediatr. 2019;62:108\u201312.","journal-title":"Korean J Pediatr"},{"key":"1015_CR52","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S0887-8994(00)00233-2","volume":"24","author":"A Tomoda","year":"2001","unstructured":"Tomoda A, Shiraishi S, Hosoya M, Hamada A, Miike T. Combined treatment with interferon-alpha and ribavirin for subacute sclerosing panencephalitis. Pediatr Neurol. 2001;24:54\u20139.","journal-title":"Pediatr Neurol"},{"key":"1015_CR53","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0387-7604(03)00017-2","volume":"25","author":"S Hara","year":"2003","unstructured":"Hara S, Kimura H, Hoshino Y, Hayashi N, Negoro T, Okumura A, et al. Combination therapy with intraventricular interferon-alpha and ribavirin for subacute sclerosing panencephalitis and monitoring measles virus RNA by quantitative PCR assay. Brain Dev. 2003;25:367\u20139.","journal-title":"Brain Dev"},{"key":"1015_CR54","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1586\/ern.12.21","volume":"12","author":"B Tatli","year":"2012","unstructured":"Tatli B, Ekici B, Ozmen M. Current therapies and future perspectives in subacute sclerosing panencephalitis. Expert Rev Neurother. 2012;12:485\u201392.","journal-title":"Expert Rev Neurother"},{"key":"1015_CR55","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1093\/ije\/dym207","volume":"36","author":"H Campbell","year":"2007","unstructured":"Campbell H, Andrews N, Brown KE, Miller E. Review of the effect of measles vaccination on the epidemiology of SSPE. Int J Epidemiol. 2007;36:1334\u201348.","journal-title":"Int J Epidemiol"},{"key":"1015_CR56","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1001\/archneur.60.4.605","volume":"60","author":"CO Hanemann","year":"2003","unstructured":"Hanemann CO, Bergmann C, Senderek J, Zerres K, Sperfeld A-D. Transient, recurrent, white matter lesions in X-linked Charcot-Marie-Tooth disease with novel connexin 32 mutation. Arch Neurol. 2003;60:605\u20139.","journal-title":"Arch Neurol"},{"key":"1015_CR57","doi-asserted-by":"publisher","first-page":"e9176","DOI":"10.1097\/MD.0000000000009176","volume":"96","author":"JK Kim","year":"2017","unstructured":"Kim JK, Han S-A, Kim SJ. X-linked Charcot-Marie-Tooth disease with GJB1 mutation presenting as acute disseminated encephalomyelitis-like illness: a case report. Medicine (Baltimore). 2017;96:e9176.","journal-title":"Medicine (Baltimore)."},{"key":"1015_CR58","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s10072-016-2537-6","volume":"37","author":"C Xie","year":"2016","unstructured":"Xie C, et al. CNS involvement in CMTX1 caused by a novel connexin 32 mutation: a 6-year follow-up in neuroimaging and nerve conduction. Neuro Sci. 2016;37:1063\u201370.","journal-title":"Neuro Sci"},{"key":"1015_CR59","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12883-014-0156-5","volume":"14","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, et al. Transient, recurrent, white matter lesions in x-linked Charcot-Marie-tooth disease with novel mutation of gap junction protein beta 1 gene in China: a case report. BMC Neurol. 2014;14:156.","journal-title":"BMC Neurol."},{"key":"1015_CR60","first-page":"243652","volume":"2013","author":"C Koros","year":"2013","unstructured":"Koros C, Evangelopoulos M-E, Kilidireas C, Andreadou E. Central nervous system demyelination in a Charcot-Marie-Tooth type 1A patient. Case Rep Neurol Med. 2013;2013:243652.","journal-title":"Case Rep Neurol Med"},{"key":"1015_CR61","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/ana.24824","volume":"81","author":"M Lee","year":"2017","unstructured":"Lee M, Park CH, Chung HK, Kim HJ, Choi Y, Yoo JH, et al. Cerebral white matter abnormalities in patients with charcot-marie-tooth disease. Ann Neurol. 2017;81:147\u201351.","journal-title":"Ann Neurol."},{"key":"1015_CR62","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1001\/archneurol.2012.122","volume":"69","author":"G Taieb","year":"2012","unstructured":"Taieb G, Duflos C, Renard D, Audoin B, Kaphan E, Pelletier J, et al. Long-term outcomes of CLIPPERS (chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids) in a consecutive series of 12 patients. Arch Neurol. 2012;69:847\u201355.","journal-title":"Arch Neurol"},{"key":"1015_CR63","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1093\/brain\/awx200","volume":"140","author":"WO Tobin","year":"2017","unstructured":"Tobin WO, Guo Y, Krecke KN, Parisi JE, Lucchinetti CF, Pittock SJ, et al. Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain. 2017;140:2415\u201325.","journal-title":"Brain"},{"key":"1015_CR64","doi-asserted-by":"publisher","first-page":"2329048X1983109","DOI":"10.1177\/2329048X19831096","volume":"6","author":"T Nemani","year":"2019","unstructured":"Nemani T, Udwadia-Hegde A, Keni Karnavat P, Kashikar R, Epari S. CLIPPERS spectrum disorder: a rare pediatric neuroinflammatory condition. Child Neurol Open. 2019;6:2329048X19831096.","journal-title":"Child Neurol Open"},{"key":"1015_CR65","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.msard.2017.07.012","volume":"17","author":"A Veerapandiyan","year":"2017","unstructured":"Veerapandiyan A, Chaudhari A, Deo P, Ming X. Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS): a pediatric case report with six year follow-up. Mult Scler Relat Disord. 2017;17:95\u20138.","journal-title":"Mult Scler Relat Disord"},{"key":"1015_CR66","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1111\/ene.13483","volume":"25","author":"G Berzero","year":"2018","unstructured":"Berzero G, Taieb G, Marignier R, Younan N, Savatovsky J, Leclercq D, et al. CLIPPERS mimickers: relapsing brainstem encephalitis associated with anti-MOG antibodies. Eur J Neurol. 2018;25:e16\u20137.","journal-title":"Eur J Neurol"},{"key":"1015_CR67","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1212\/WNL.0000000000001370","volume":"84","author":"M Symmonds","year":"2015","unstructured":"Symmonds M, Waters PJ, K\u00fcker W, Leite MI, Schulz UG. Anti-MOG antibodies with longitudinally extensive transverse myelitis preceded by CLIPPERS. Neurology. 2015;84:1177\u20139.","journal-title":"Neurology"},{"key":"1015_CR68","doi-asserted-by":"publisher","first-page":"e545","DOI":"10.1212\/NXI.0000000000000545","volume":"6","author":"T Rempe","year":"2019","unstructured":"Rempe T, et al. A case of CLIPPERS syndrome responsive to tocilizumab. Neurol Neuroimmunol. Neuroinflamm. 2019;6:e545.","journal-title":"Neurol Neuroimmunol. Neuroinflamm"},{"key":"1015_CR69","doi-asserted-by":"publisher","first-page":"e448","DOI":"10.1212\/NXI.0000000000000448","volume":"5","author":"VP Cipriani","year":"2018","unstructured":"Cipriani VP, Arndt N, Pytel P, Reder AT, Javed A. Effective treatment of CLIPPERS with long-term use of rituximab. Neurol Neuroimmunol Neuroinflamm. 2018;5:e448.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"1015_CR70","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.3389\/fimmu.2018.02802","volume":"9","author":"F Shan","year":"2018","unstructured":"Shan F, Long Y, Qiu W. Autoimmune glial fibrillary acidic protein astrocytopathy: a review of the literature. Front Immunol. 2018;9:2802.","journal-title":"Front Immunol"},{"key":"1015_CR71","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jneuroim.2018.04.016","volume":"321","author":"D Dubey","year":"2018","unstructured":"Dubey D, Hinson SR, Jolliffe EA, Zekeridou A, Flanagan EP, Pittock SJ, et al. Autoimmune GFAP astrocytopathy: prospective evaluation of 90 patients in 1 year. J Neuroimmunol. 2018;321:157\u201363.","journal-title":"J Neuroimmunol"},{"key":"1015_CR72","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.msard.2018.12.008","volume":"29","author":"C Francisco","year":"2019","unstructured":"Francisco C, Meddles K, Waubant E. Pediatric glial fibrillary acidic protein meningoencephalomyelitis: a case report and review of the literature. Mult Scler Relat Disord. 2019;29:148\u201352.","journal-title":"Mult Scler Relat Disord"},{"key":"1015_CR73","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1001\/jamaneurol.2016.2549","volume":"73","author":"B Fang","year":"2016","unstructured":"\u2022\u2022 Fang B, McKeon A, Hinson SR, Kryzer TJ, Pittock SJ, Aksamit AJ, et al. Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis. JAMA Neurol. 2016;73:1297\u2013307 This is the first characterization of the clinical presentation, response to corticosteroids, and associated neoplasms in patients with seropositivity for GFAP immunoglobulin.","journal-title":"JAMA Neurol"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-019-1015-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-019-1015-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-019-1015-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T21:34:28Z","timestamp":1650404068000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-019-1015-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,26]]},"references-count":73,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1015"],"URL":"https:\/\/doi.org\/10.1007\/s11910-019-1015-y","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,26]]},"assertion":[{"value":"26 November 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Regina M. Troxell and Alison Christy each declare no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"95"}}